08th week of 2022 patent applcation highlights part 9 |
Patent application number | Title | Published |
20220054494 | METHODS FOR TREATING BLADDER AND URETHRA DYSFUNCTION AND DISEASE | 2022-02-24 |
20220054495 | COMPOSITIONS AND METHODS FOR ENHANCED DELIVERY OF ANTIVIRAL AGENTS | 2022-02-24 |
20220054496 | MODULATION OF TRF1 FOR BRAIN CANCER TREATMENT | 2022-02-24 |
20220054497 | PREVENTION OF ATHEROSCLEROTIC EVENTS WITH DIRECT FACTOR Xa INHIBITORS | 2022-02-24 |
20220054498 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2022-02-24 |
20220054499 | SMALL MOLECULES FOR MOUSE SATELLITE CELL PROLIFERATION | 2022-02-24 |
20220054500 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | 2022-02-24 |
20220054501 | MEDICATION AGAINST ESTROGEN-RECEPTOR b (ER.beta) POSITIVE BREAST TUMOR | 2022-02-24 |
20220054502 | ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF ACUTE HEART FAILURE (AHF) | 2022-02-24 |
20220054503 | SYSTEM FOR PROVIDING BIRTH CONTROL | 2022-02-24 |
20220054504 | Novel therapeutic agent for inflammatory disease | 2022-02-24 |
20220054505 | Sulfated-Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Tissue Regeneration | 2022-02-24 |
20220054506 | IMMUNOREGULATORY AGENT | 2022-02-24 |
20220054507 | COMBINATIONAL DRUG THERAPIES | 2022-02-24 |
20220054508 | COMPOSITION COMPRISING DUTASTERIDE | 2022-02-24 |
20220054509 | METHODS OF TREATMENT FOR DISEASE FROM CORONAVIRUS EXPOSURE | 2022-02-24 |
20220054510 | USE OF 1-ALPHA-HYDROXYVITAMIN D5 AND RELATED COMPOUNDS AS PROPHYLACTIC OR THERAPEUTIC AGENTS FOR SARS-COV-2 (COVID-19 VIRUS) AND RELATED INFECTIONS | 2022-02-24 |
20220054511 | TOPICAL DOXYCYCLINE HYDROGEL WITH IMPROVED LONG-TERM STABILITY | 2022-02-24 |
20220054512 | CD73 INHIBITORS | 2022-02-24 |
20220054513 | COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR | 2022-02-24 |
20220054514 | HUMAN MILK FORTIFIER COMPOSITION | 2022-02-24 |
20220054515 | COMPOSITION AND METHOD FOR PROMOTING INTESTINAL BARRIER HEALING | 2022-02-24 |
20220054516 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | 2022-02-24 |
20220054517 | TOBRAMYCIN COMPOUND-COPOLYMER CONJUGATES AND DERIVATIVE COMPOSITIONS | 2022-02-24 |
20220054518 | TOBRAMYCIN COMPOUND CONJUGATE FORMULATIONS | 2022-02-24 |
20220054519 | EFFICIENT TOBRAMYCIN COMPOUND CONJUGATE COMPOSITIONS | 2022-02-24 |
20220054520 | OPHTHALMIC COMPOSITION CONTAINING DIQUAFOSOL OR SALT THEREOF, VINYL-BASED POLYMER AND CELLULOSE-BASED POLYMER | 2022-02-24 |
20220054521 | Method and Compositions for Treating Coronavirus Infection | 2022-02-24 |
20220054522 | METHODS FOR THE USE OF 5'-ADENOSINE DIPHOSPHATE RIBOSE (ADPR) | 2022-02-24 |
20220054523 | COMPOUNDS,COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | 2022-02-24 |
20220054524 | NEW CONJUGATED NUCLEIC ACID MOLECULES AND THEIR USES | 2022-02-24 |
20220054525 | DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS | 2022-02-24 |
20220054526 | Antisense Compounds Targeting Genes Associated with Cystic Fibrosis | 2022-02-24 |
20220054527 | METHOD OF TREATING A DISEASE USING A GLYCOLYTIC DEPENDENT COMPOUND | 2022-02-24 |
20220054528 | TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS | 2022-02-24 |
20220054529 | HEMOSTATIC AGENT AND METHOD OF PRODUCTION THEREOF | 2022-02-24 |
20220054530 | COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS | 2022-02-24 |
20220054531 | TREATMENT OF ACUTE MYELOID LEUKEMIA WITH HYPOMETHYLATING AGENTS AND 2-O, 3-O DESULFATED HEPARINOIDS | 2022-02-24 |
20220054532 | VETERINARY COMPOSITIONS AND METHODS OF USE THEREFOR | 2022-02-24 |
20220054533 | Prebiotic Composition for Butyric Acid Bacteria | 2022-02-24 |
20220054534 | INDUCING CASPASE ACTIVITY | 2022-02-24 |
20220054535 | STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION | 2022-02-24 |
20220054536 | NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS | 2022-02-24 |
20220054537 | MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS | 2022-02-24 |
20220054538 | ANTI-HELICOBACTER AGENT AND METHOD FOR THE USE THEREOF | 2022-02-24 |
20220054539 | DISINFECTION AND DEODORIZING OF PAP EQUIPMENT USING LOW CONCENTRATION HYPOCHLOROUS ACID SOLUTIONS | 2022-02-24 |
20220054540 | Ferric Carboxymaltose In The Treatment Of Heart Failure And In The Treatment Of Congestion In Heart Failure | 2022-02-24 |
20220054541 | METHOD FOR TREATING INFLAMMATORY BOWEL DISEASES | 2022-02-24 |
20220054542 | METHOD OF TREATING EQUINE JOINT INFLAMMATION | 2022-02-24 |
20220054543 | Enteric Use of Potassium Permanganate in Humans and Animals | 2022-02-24 |
20220054544 | CONDITIONALLY ACTIVE RECEPTORS | 2022-02-24 |
20220054545 | ANTI-GPC3 CHIMERIC ANTIGEN RECEPTORS (CARs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF | 2022-02-24 |
20220054546 | CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF | 2022-02-24 |
20220054547 | METHOD OF TREATING AUTOIMMUNE AND INFLAMMATORY DISEASES USING B CELLS | 2022-02-24 |
20220054548 | MIRNA FOR USE IN THERAPY | 2022-02-24 |
20220054549 | METHODS AND COMPOSITIONS FOR ENGINEERING CD4-DEFICIENT CAR T CELLS AND ANTI-CD4 CAR T CELLS AND USES THEREOF | 2022-02-24 |
20220054550 | COMBINATION THERAPIES | 2022-02-24 |
20220054551 | COMPOSITIONS AND METHODS FOR TREATING CEACAM POSITIVE CANCERS | 2022-02-24 |
20220054552 | Cellular pharmaceutical product containing quantified doubling level stem cells and a method for producing it | 2022-02-24 |
20220054553 | METHODS OF TREATING ISCHEMIA | 2022-02-24 |
20220054554 | Scalable Production of Standardized Extracellular Vesicles, Extracellular Vesicle Preparations and Uses Thereof | 2022-02-24 |
20220054555 | ENHANCED OSTEOGENIC COMPOSITION | 2022-02-24 |
20220054556 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALLERGY | 2022-02-24 |
20220054557 | IMMUNOSTIMULANT FOR USE AGAINST PATHOGENS | 2022-02-24 |
20220054558 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2022-02-24 |
20220054559 | COMPOSITIONS AND METHODS FOR ENHANCING EXERCISE ENDURANCE | 2022-02-24 |
20220054560 | CONSORTIA OF LIVING BACTERIA USEFUL FOR TREATMENT OF COLORECTAL CANCER | 2022-02-24 |
20220054561 | LACHNOSPIRACEAE MITIGATES AGAINST RADIATION-INDUCED HEMATOPOIETIC/GASTROINTESTINAL INJURY AND DEATH, AND PROMOTES CANCER CONTROL BY RADIATION | 2022-02-24 |
20220054562 | COMBINATIONS OF ENGINEERED ANTIMICROBIAL PROBIOTICS FOR TREATMENT OF GASTROINTESTINAL TRACT PATHOGENS | 2022-02-24 |
20220054563 | DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES | 2022-02-24 |
20220054564 | SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY | 2022-02-24 |
20220054565 | Platform Oncolytic Vector for Systemic Delivery | 2022-02-24 |
20220054566 | ANTIVIRAL COMPOSITION HAVING ANTIVIRAL ACTIVITY AGAINST CORONAVIRUS AND VARIANT VIRUSES THEREOF | 2022-02-24 |
20220054567 | COMPOSITION FOR THE TREATMENT OF ACNE | 2022-02-24 |
20220054568 | SYSTEMS, METHODS, AND EQUIPMENT FOR CHEMICAL EXTRACTION | 2022-02-24 |
20220054569 | METHOD FOR TREATING A TUBERCULOUS PROSTATITIS SIDE EFFECT CAUSED BY BCG PERFUSION THERAPY FOR BLADDER CANCER | 2022-02-24 |
20220054570 | COMPOSITION COMPRISING ELECAMPANE EXTRACT FOR ALLEVIATING PREMENSTRUAL SYNDROME SYMPTOM | 2022-02-24 |
20220054571 | COMPOSITION FOR PREVENTING OR TREATING GASTRITIS OR PEPTIC ULCER | 2022-02-24 |
20220054572 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2022-02-24 |
20220054573 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2022-02-24 |
20220054574 | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2022-02-24 |
20220054575 | PROTECTION AGAINST CORONAVIRUS INFECTION BY EXTRACTS AND EXTRACT COMPONENTS | 2022-02-24 |
20220054576 | PHARMACEUTICAL COMPOSITION COMPRISING EXTRACT FROM CAMELLIA JAPONICA AS ACTIVE INGREDIENT FOR PREVENTION AND TREATMENT OF VIRAL INFECTION | 2022-02-24 |
20220054577 | MATERNAL BREAST MILK WITH NATURAL BIOACTIVE NUTRACEUTICAL EXTRACTS | 2022-02-24 |
20220054578 | COMPOSITION AND METHOD FOR ORAL SUPPLEMENT REPELLING BITING INSECTS | 2022-02-24 |
20220054579 | METHODS AND COMPOSITIONS FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS | 2022-02-24 |
20220054580 | FORMULATION COMPRISING WATER SOLUBLE PARTICLES OF A NON-CURCUMINOID AND A CURCUMINOID | 2022-02-24 |
20220054581 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATION | 2022-02-24 |
20220054582 | METHOD FOR MANUFACTURING A SOLID FORMULATION FOR ORAL ADMINISTRATION, ASSOCIATED FACILITY AND SOLID FORUMULATION | 2022-02-24 |
20220054583 | PEPTIDES AND MEDICAL USES THEREOF | 2022-02-24 |
20220054584 | ANTIMICROBIAL FUSION PEPTIDES | 2022-02-24 |
20220054585 | IMMUNOMODULATORY & ONCOLYTIC MINICELLS AND METHODS OF USE | 2022-02-24 |
20220054586 | LIQUID COMPOSITION COMPRISING PROTEIN | 2022-02-24 |
20220054587 | COMPOSITIONS AND METHODS OF USE FOR SECRETOGLOBINS TO PROTECT THE GLYCOCALYX VIA INTERACTIONS WITH HEPARAN SULFATE PROTEOGLYCAN PROTEINS | 2022-02-24 |
20220054588 | USE OF SAP FOR THE TREATMENT OF EUROTIOMYCETES FUNGI INFECTIONS | 2022-02-24 |
20220054589 | Compositions Comprising Antimicrobial Peptides | 2022-02-24 |
20220054590 | PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF | 2022-02-24 |
20220054591 | METHODS OF TREATING OF INFLAMMATORY BOWEL DISEASE AND PARASITE INFECTION | 2022-02-24 |
20220054592 | METHODS FOR TREATMENT OF COVID-19 SYNDROME | 2022-02-24 |
20220054593 | LONG-ACTING FATTY ACID-CONJUGATED GnRH DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2022-02-24 |